Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Madhura P. Dixit"'
Autor:
Mrunali D. Dhokne, Madhura P. Dixit, Mayur B. Kale, Manish M. Aglawe, Milind J. Umekar, Brijesh G. Taksande
Publikováno v:
INNOSC Theranostics and Pharmacological Sciences. 5:1-10
N-methyl-D-aspartate receptor (NMDAR) antagonist, a subclass of glutamate receptors or nitric oxide synthase (NOS) inhibitors, prevents neuronal plasticity. However, neural plasticity plays a major role in the pain caused by inflammation and neuropat
Publikováno v:
Indian Journal of Pharmacy and Pharmacology. 7:213-221
The blood brain barrier (BBB) segregates the central nervous system from the systemic circulation nevertheless also retard the effective treatment of central nervous system diseases. Intrinsically, the BBB prevents contagions and pathogens by invade
Autor:
Madhura P. Dixit, Shivkumar S. Sammeta, Mrunali D. Dhokne, Shubhada Mangrulkar, Manoj A. Upadhya, Milind J. Umekar, Brijesh G. Taksande, Nandkishor R. Kotagale
Publikováno v:
Brain research bulletin. 191
Antipsychotic-induced obesity affects millions of people and is a serious health condition worldwide. Olanzapine is the most widely prescribed antipsychotic agent with high obesogenic potential. However, the exact mechanism by which it causes its met
Autor:
Sarita Chauragade, Madhura P. Dixit, Brijesh G. Taksande, Nandkishor R. Kotagale, Shubham Nilkanth Rahmatkar, Milind J. Umekar, Chandrabhan T. Chopde
Publikováno v:
NeuroToxicology. 80:1-11
Alzheimer's disease (AD) is a chronic and progressive neurodegenerative disorder characterized by abnormal accumulation of extracellular β-amyloid (Aβ) plaques and neuronal damage. The present study investigated the effect of chronic intra-hippocam
Autor:
Milind J. Umekar, Rajshree Fating, Madhura P. Dixit, Rupali Deshmukh, Brijesh G. Taksande, Nandkishor R. Kotagale
Publikováno v:
Brain Research Bulletin. 160:56-64
Extensive clinical and experimental studies established that depression and mood disorders are highly prevalent neuropsychiatric conditions in Alzheimer’s disease (AD). However, its neurochemical basis is not clearly understood. Thus, understanding
Publikováno v:
International Journal of Pharmaceutical Chemistry and Analysis. 7:26-31
The aim of the research work was to develop a method for comparative evaluation of dissolution profile of two different brands of Teneligliptin hydrobromide hydrate drug in its formulations containing using UV Spectrophotometer. Simple, precise and a
Autor:
Madhura P, Dixit, Shubham N, Rahmatkar, Prachi, Raut, Milind J, Umekar, Brijesh G, Taksande, Nandkishor R, Kotagale
Publikováno v:
Neuroscience letters. 740
Alzheimer's disease is an age related progressive neurodegenerative disorder characterized by decline in cognitive functions, such as memory loss and behavioural abnormalities. The present study sought to assess alterations in agmatine metabolism in
Autor:
Madhura P. Dixit, Brijesh G. Taksande, Nandkishor R. Kotagale, Milind J. Umekar, Prachi Raut, Shubham Nilkanth Rahmatkar
Publikováno v:
Neuroscience Letters. 740:135447
Alzheimer's disease is an age related progressive neurodegenerative disorder characterized by decline in cognitive functions, such as memory loss and behavioural abnormalities. The present study sought to assess alterations in agmatine metabolism in
Autor:
Brijesh G. Taksande, Nandkishor R. Kotagale, Madhura P. Dixit, Harshal Garmelwar, Milind J. Umekar, Shraddha Bhondekar
Publikováno v:
Pharmacology Biochemistry and Behavior. 196:172976
s Agmatine is a biogenic amine synthesized following decarboxylation of L-arginine by the enzyme arginine decarboxylase and exhibits favourable outcome in neurodegenerative disorders. Present study was designed to examine the relationship between agm
Autor:
Jay N. Sakaria, Dharmesh S. Faldu, Brijesh G. Taksande, Nandkishor R. Kotagale, Manish M. Aglawe, Milind J. Umekar, Madhura P. Dixit
Publikováno v:
European Journal of Pharmacology. 720:115-120
Chronic stress exposure and resulting dysregulation of the hypothalamic pituitary adrenal axis develops susceptibility to variety of neurological and psychiatric disorders. Agmatine, a putative neurotransmitter has been reported to be released in res